If you are deciding what to do with Sankyo stock right now, you are definitely not alone. The conversation around Sankyo has heated up in recent months and for good reason, especially if you have been ...

During a live event, Shirish M. Gadgeel, MD, discussed different management approaches to the improve tolerability of ...

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma ...

The United States reported the highest number of new cases of high- and low-grade serous ovarian cancer (HGSOC and LGSOC) in ...

FDA designates raludotatug deruxtecan as a breakthrough therapy for treating platinum-resistant ovarian cancers, enhancing ...

Stocks in developed economies outside the U.S. tend to trade at lower valuations. Some of the companies are expected to expand their businesses rapidly over the next two years.

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum BOSTON, MA / ACCESS Newswire / September 16, ...

Importance Little research has been done on post-COVID symptoms at 24 months postinfection and on the association these may ...

Astute Analytica stands out as a premier provider of comprehensive Shingles Vaccine Market research reports specifically tailored for the healthcare sector. Our commitment lies in delivering valuable ...

The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast ...